Immunologic Deficiency Syndromes
"Immunologic Deficiency Syndromes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.
| Descriptor ID |
D007153
|
| MeSH Number(s) |
C20.673
|
| Concept/Terms |
Immunologic Deficiency Syndromes- Immunologic Deficiency Syndromes
- Deficiency Syndromes, Immunologic
- Immunological Deficiency Syndromes
- Deficiency Syndrome, Immunological
- Deficiency Syndromes, Immunological
- Immunological Deficiency Syndrome
- Syndrome, Immunological Deficiency
- Syndromes, Immunological Deficiency
- Deficiency Syndrome, Immunologic
- Syndrome, Immunologic Deficiency
- Syndromes, Immunologic Deficiency
- Immunologic Deficiency Syndrome
Antibody Deficiency Syndrome- Antibody Deficiency Syndrome
- Deficiency Syndromes, Antibody
- Antibody Deficiency Syndromes
- Deficiency Syndrome, Antibody
- Syndrome, Antibody Deficiency
- Syndromes, Antibody Deficiency
|
Below are MeSH descriptors whose meaning is more general than "Immunologic Deficiency Syndromes".
Below are MeSH descriptors whose meaning is more specific than "Immunologic Deficiency Syndromes".
This graph shows the total number of publications written about "Immunologic Deficiency Syndromes" by people in this website by year, and whether "Immunologic Deficiency Syndromes" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2013 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Immunologic Deficiency Syndromes" by people in Profiles.
-
Dominant-negative IKZF1 mutations cause a T, B, and myeloid cell combined immunodeficiency. J Clin Invest. 2018 07 02; 128(7):3071-3087.
-
Trends in hematopoietic stem cell transplant activity in Lebanon. Hematol Oncol Stem Cell Ther. 2017 Dec; 10(4):315-320.
-
The paracaspase MALT1 cleaves HOIL1 reducing linear ubiquitination by LUBAC to dampen lymphocyte NF-?B signalling. Nat Commun. 2015 Nov 03; 6:8777.
-
Human immunoglobulin constant heavy G chain (IGHG) (Fc?) (GM) genes, defining innate variants of IgG molecules and B cells, have impact on disease and therapy. Clin Immunol. 2013 Dec; 149(3):475-86.
-
Orbital lymphoma in the setting of idiopathic CD4+ lymphocytopenia (HIV-negative AIDS). Ophthalmic Plast Reconstr Surg. 2011 Sep-Oct; 27(5):e134-6.
-
Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome. Arthritis Res Ther. 2005; 7(1):R30-7.
-
Determination of cytokine responses using a multiplexed fluorescent microsphere immunoassay. Am J Clin Pathol. 2002 Sep; 118(3):346-53.
-
Natural history and treatment of varicella-zoster in high-risk populations. J Hosp Infect. 1991 Jun; 18 Suppl A:317-29.
-
Common variable immune deficiency syndrome associated with lupus anticoagulant. Clin Exp Rheumatol. 1985 Jan-Mar; 3(1):71-3.
-
An open-label trial of immunomodulation therapy with inosiplex (Isoprinosine) in patients with alopecia totalis and cell-mediated immunodeficiency. J Am Acad Dermatol. 1984 Aug; 11(2 Pt 1):224-30.